Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -89.93% is 208% below its 5-year average of -29.17%, near the low end of its 5-year range (-89.93%–16.90%).
As of the fiscal period ended Tuesday, June 30, 2026. 36.39% below its 12-month average of -65.94%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -89.93%.
RETURN ON INVESTED CAPITAL (ROIC)
-89.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-65.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-40.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-29.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-36.39%
CURRENT VS 3Y AVG
-124.16%
CURRENT VS 5Y AVG
-208.34%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 644 covered companies
CURRENT VS SECTOR MEDIAN
-169.39%
vs the sector median at left
Atea Pharmaceuticals, Inc.
Market Cap
$413.34M
Return on Invested Capital (ROIC)
-89.93%
TTM Avg
-65.94%
3Y Avg
-40.12%
5Y Avg
-29.17%
Market Cap
$411.24M
Return on Invested Capital (ROIC)
-25.26%
TTM Avg
-29.12%
3Y Avg
-26.65%
5Y Avg
-26.65%
Market Cap
$414.89M
Return on Invested Capital (ROIC)
-54.45%
TTM Avg
-31.52%
3Y Avg
-36.49%
5Y Avg
-36.90%
Market Cap
$405.18M
Return on Invested Capital (ROIC)
-19.13%
TTM Avg
-11.02%
3Y Avg
-12.07%
5Y Avg
-13.96%
Market Cap
$420.39M
Return on Invested Capital (ROIC)
-46.16%
TTM Avg
-62.80%
3Y Avg
-62.80%
5Y Avg
-62.80%
Market Cap
$403.02M
Return on Invested Capital (ROIC)
-36.54%
TTM Avg
-40.95%
3Y Avg
-100.88%
5Y Avg
-100.88%
Market Cap
$397.20M
Return on Invested Capital (ROIC)
-69.35%
TTM Avg
-52.27%
3Y Avg
-73.46%
5Y Avg
-73.46%
Market Cap
$389.64M
Return on Invested Capital (ROIC)
-80.67%
TTM Avg
-59.31%
3Y Avg
-71.22%
5Y Avg
-64.55%
Market Cap
$438.87M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | $413.34M | -89.93% | -65.94% | -40.12% | -29.17% |
| Shoulder Innovations, Inc. (SI)vs › | $411.24M | -25.26% | -29.12% | -26.65% | -26.65% |
| Neurogene Inc. (NGNE)vs › | $414.89M | -54.45% | -31.52% | -36.49% | -36.90% |
| Myriad Genetics, Inc. (MYGN)vs › | $405.18M | -19.13% | -11.02% | -12.07% | -13.96% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $420.39M | -46.16% | -62.80% | -62.80% | -62.80% |
| Carlsmed, Inc. (CARL)vs › | $403.02M | -36.54% | -40.95% | -100.88% | -100.88% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $397.20M | -69.35% | -52.27% | -73.46% | -73.46% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $389.64M | -80.67% | -59.31% | -71.22% | -64.55% |
| NeoGenomics, Inc. (NEO)vs › | $438.87M | -5.29% | -5.58% | -6.88% | -5.95% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $380.30M | -54.07% | -33.14% | -21.50% | -27.82% |
ROIC
-89.9%
ROE
-81.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -89.93% |
| 2026-03-31 | -81.02% |
| 2025-12-31 | -65.47% |
| 2025-09-30 | -51.11% |
| 2025-06-30 | -42.16% |
| 2025-03-31 | -38.78% |
| 2024-12-31 | -43.26% |
| 2024-09-30 | -43.05% |
| 2024-06-30 | -42.19% |
| 2024-03-31 | -37.60% |
| 2023-12-31 | -29.18% |
| 2023-09-30 | -26.73% |
| 2023-06-30 | -21.81% |
| 2023-03-31 | -20.78% |
| 2022-12-31 | -20.15% |
| 2022-09-30 | 4.49% |
| 2022-06-30 | 2.20% |
| 2022-03-31 | 7.00% |
| 2021-12-31 | 16.90% |
| 2021-09-30 | 4.23% |
| 2021-06-30 | 5.88% |
| 2021-03-31 | 4.04% |
| 2020-12-31 | -2.01% |
| 2020-09-30 | -36.69% |
| 2020-06-30 | -20.03% |
| 2020-03-31 | -102.88% |
| 2019-12-31 | -74.39% |
